Method of treating pulmonary inflammation
US5080899A · kind A · utility
170Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 1991 |
| Grant date | Jan 14, 1992 |
| Priority date | — |
| Expiry date | Feb 22, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method of preventing or reversing pulmonary inflammation in a mammal by administering an effective amount of rapamycin orally, parenterally, intranasally, or intrabronchially. As such, rapamycin is useful in providing the symptomatic relief of diseases in which pulmonary inflammation is a component such as, asthma, chronic obstructive pulmonary disease, emphysema, acute respiratory distress syndrome, bronchitis, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.